Method for synthesizing and preparing vildagliptin
By preparing the reaction of (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile and 3-amino-1-amantanol, many by-products in viragliptin synthesis in the prior art were solved. and the problem of low purity, high purity and high yield products are achieved, suitable for industrial production.
Patent Information
- Application Number
- CN202310619024.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-30
- Publication Date
- 2024-12-03
AI Technical Summary
The existing vidagliptin synthesis methods lead to more by-products, the main products have low purity, and the process conditions are not suitable for industrial production.
A new synthetic preparation method is adopted, including step 1: preparation (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile and step 2: 3-amino-1-adamantanol and the compound The reaction conditions are controlled to reduce impurity generation and improve yield and purity by a specific combination of solvents, catalysts and desiccants.
It effectively reduces the generation of impurities, improves the yield and purity of the product, and is gentle in process conditions, and is suitable for industrial production.
Smart Images

Figure BDA0004254744890000011
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field related to biopharmaceutical synthesis, and in particular to a method for synthesizing vildagliptin. Background Art
[0002] Vildagliptin, chemical name (S)-1-[[3-hydroxy-1-adamantanamine)amino]acetyl]-2-cyanopyrrolidine, has a structural formula as shown below (Formula I). It is a new oral hypoglycemic drug developed by Novartis and was approved for marketing by the European Medicines Agency in 2008. Vildagliptin is an oral hypoglycemic drug belonging to the class of type IV dipeptidyl peptidase (DPP-IV) inhibitors. Its mechanism of action is to inhibit the activity of the enzyme by binding to DPP-IV to form a complex, thereby increasing the concentration of glucagon-like peptide 1 (GLP-1) and promoting the production of insulin by pancreatic β cells, while reducing the concentration of glucagon, thereby reducing blood sugar.
[0003]
[0004] For example, the patent publication number WO0034241 reports a method for synthesizing vildagliptin, using L-prolineamide as a raw material, chloroacetylation in a potassium carbonate and tetrahydrofuran system, and then using trifluoroacetic anhydride as a dehydrating agent to dehydrate the amide group into a nitrile group. (S)-1-(2-chloroacetyl chloride)pyrrolidine-2-carbonitrile and 3-aminoadamantanol are used to prepare vildagliptin in a potassium carbonate and dichloromethane system. The above method will result in more by-products, resulting in a lower purity of the main product.
[0005] In view of the above-mentioned defects, the inventors of the present invention have actively conducted research and innovation in order to create a synthetic preparation method of vildagliptin to make it more valuable for industrial use. Summary of the invention
[0006] In order to solve the above technical problems, the object of the present invention is to provide a method for synthesizing vildagliptin.
[0007] To achieve the above object, the present invention adopts the following technical solution:
[0008] A synthetic preparation method of vildagliptin, the synthetic preparation method sequentially comprising the following steps:
[0009] Step 1, preparation of (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile:
[0010] Step 11, mixing L-prolineamide, an organic solvent 1 and di-tert-butyl dicarbonate for reaction, washing with water and then distilling to obtain N-Boc-L-prolineamide;
[0011] Step 12, add N, N-dimethylformamide to the N-Boc-L-proline amide obtained above until it becomes clear, filter the solid, evaporate the solvent, add dichloromethane until it dissolves, wash the organic phase with water, wash and dry, add p-toluenesulfonic acid, reflux for 1-2h, distill to remove the solvent, add acetonitrile, cool by 0-3°C, filter to obtain (S)-pyrrolidine-2-carbonitrile p-toluenesulfonate;
[0012] Step 13, dissolving the (S)-pyrrolidine-2-carbonitrile p-toluenesulfonate obtained above in dichloromethane and triethylamine, adding chloroacetyl chloride to react, washing with 10% sodium bicarbonate aqueous solution and purified water, removing the solvent, and crystallizing with n-hexane to obtain (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile;
[0013] Step 2, 3-amino-1-adamantanol reacts with (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile to prepare vildagliptin:
[0014] Step 21, adding an organic solvent 2 and an organic base to a reaction bottle, and then adding 3-amino-1-adamantanol and (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile, heating to 40-55° C., reacting for 10-12 hours, to obtain a reaction solution;
[0015] Step 22, subjecting the reaction solution obtained in the above step 21 to reduced pressure distillation, cooling it to 30-45° C., adding an organic solvent and an adsorbent, and stirring for 1-2 hours;
[0016] Step 23, after the stirring in the above step 22, the mixture is allowed to stand for stratification, and the filter residue is washed three times with an organic solvent to obtain an organic phase extract;
[0017] Step 24, adding a desiccant to the organic phase extract obtained in the above step 23 for drying, filtering and concentrating under reduced pressure to obtain a concentrated solution;
[0018] Step 23: Add organic solvent 3 to the concentrated solution obtained in the above step 24, heat it until it is completely dissolved, cool it to 0-3°C for crystallization, filter it, and vacuum dry it to obtain vildagliptin.
[0019] As a further improvement of the present invention, the organic solvent one is a combination of one or more of dichloromethane, chloroform, ethyl acetate, and toluene; the organic solvent two is a combination of one or more of tetrahydrofuran, dimethylacetamide, dichloromethane, ethyl acetate, methanol, and acetone; the organic solvent three is a combination of one or more of toluene, dichloromethane, chloroform, ethyl acetate, methanol, ethanol, isopropanol, acetone, and butanone.
[0020] As a further improvement of the present invention, catalyst one is further added in step 11, and catalyst one is a combination of one or more of butylammonium bromide, tetrabutylammonium chloride, and benzyltriethylammonium chloride; catalyst two is further added in step 21, and catalyst two is potassium iodide.
[0021] As a further improvement of the present invention, the molar ratio of p-toluenesulfonic acid to L-prolineamide is 1.0-1.2:1.
[0022] As a further improvement of the present invention, the molar ratio of chloroacetyl chloride to (S)-pyrrolidine-2-carbonitrile p-toluenesulfonate is 1.0-1.2:1.
[0023] As a further improvement of the present invention, the molar ratio of 3-amino-1-adamantanol to (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile is 1.0-2.0:0.5-1.2.
[0024] As a further improvement of the present invention, the adsorbent is one or a combination of more than one of alkaline alumina and silica gel.
[0025] As a further improvement of the present invention, the desiccant is one or a combination of more than one of anhydrous magnesium sulfate, anhydrous sodium sulfate, anhydrous calcium chloride, phosphorus pentoxide, and anhydrous potassium carbonate.
[0026] As a further improvement of the present invention, the vacuum drying condition is: vacuum drying at 40-50° C. for 5-8 hours.
[0027] By means of the above scheme, the present invention has at least the following advantages:
[0028] The present invention reduces the generation of impurities from the source of each step of the reaction, avoids the loss of product yield caused by treating impurities in the subsequent crystallization process, and the selected raw materials have low cost and high yield and purity;
[0029] The overall process of the present invention has mild reaction conditions, stable process materials and is suitable for the needs of industrial production.
[0030] The above description is only an overview of the technical solution of the present invention. In order to more clearly understand the technical means of the present invention and implement it according to the contents of the specification, the preferred embodiments of the present invention are described in detail as follows. DETAILED DESCRIPTION
[0031] The following examples are used to illustrate the present invention, but are not intended to limit the scope of the present invention.
[0032] In order to make those skilled in the art better understand the scheme of the present invention, the technical scheme in the embodiment of the present invention will be clearly and completely described below in conjunction with the embodiment of the present invention. Obviously, the described embodiment is only a part of the embodiment of the present invention, rather than all the embodiments. The components of the embodiment of the present invention generally shown here can be arranged and designed in various configurations. Therefore, the following detailed description of the embodiment of the present invention is not intended to limit the scope of the invention claimed for protection, but merely represents the selected embodiment of the present invention. Based on the embodiment of the present invention, all other embodiments obtained by those skilled in the art without making creative work belong to the scope of protection of the present invention.
[0033] A synthetic preparation method of vildagliptin, the synthetic preparation method sequentially comprising the following steps:
[0034] Step 1, preparation of (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile:
[0035] Step 11, mixing L-prolineamide, an organic solvent 1 and di-tert-butyl dicarbonate for reaction, washing with water and then distilling to obtain N-Boc-L-prolineamide;
[0036] Step 12, add N, N-dimethylformamide to the N-Boc-L-proline amide obtained above until it becomes clear, filter the solid, evaporate the solvent, add dichloromethane until it dissolves, wash the organic phase with water, wash and dry, add p-toluenesulfonic acid, reflux for 1-2h, distill to remove the solvent, add acetonitrile, cool by 0-3°C, filter to obtain (S)-pyrrolidine-2-carbonitrile p-toluenesulfonate;
[0037] Step 13, dissolving the (S)-pyrrolidine-2-carbonitrile p-toluenesulfonate obtained above in dichloromethane and triethylamine, adding chloroacetyl chloride to react, washing with 10% sodium bicarbonate aqueous solution and purified water, removing the solvent, and crystallizing with n-hexane to obtain (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile;
[0038] Step 2, 3-amino-1-adamantanol reacts with (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile to prepare vildagliptin:
[0039] Step 21, adding an organic solvent 2 and an organic base to a reaction bottle, and then adding 3-amino-1-adamantanol and (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile, heating to 40-55° C., reacting for 10-12 hours, to obtain a reaction solution;
[0040] Step 22, subjecting the reaction solution obtained in the above step 21 to reduced pressure distillation, cooling it to 30-45° C., adding an organic solvent and an adsorbent, and stirring for 1-2 hours;
[0041] Step 23, after the stirring in the above step 22, the mixture is allowed to stand for stratification, and the filter residue is washed three times with an organic solvent to obtain an organic phase extract;
[0042] Step 24, adding a desiccant to the organic phase extract obtained in the above step 23 for drying, filtering and concentrating under reduced pressure to obtain a concentrated solution;
[0043] Step 23: Add organic solvent 3 to the concentrated solution obtained in the above step 24, heat it until it is completely dissolved, cool it to 0-3°C for crystallization, filter it, and vacuum dry it to obtain vildagliptin.
[0044] Preferably, organic solvent one is a combination of one or more of dichloromethane, chloroform, ethyl acetate, and toluene; organic solvent two is a combination of one or more of tetrahydrofuran, dimethylacetamide, dichloromethane, ethyl acetate, methanol, and acetone; organic solvent three is a combination of one or more of toluene, dichloromethane, chloroform, ethyl acetate, methanol, ethanol, isopropanol, acetone, and butanone.
[0045] Preferably, in step 11, catalyst 1 is also added, and catalyst 1 is one or more of butylammonium bromide, tetrabutylammonium chloride, and benzyltriethylammonium chloride. A combination of more than one of catalyst 1 and catalyst 2 is also added in step 21, and catalyst 2 is potassium iodide.
[0046] Preferably, the molar ratio of p-toluenesulfonic acid to L-prolineamide is 1.0-1.2:1.
[0047] Preferably, the molar ratio of chloroacetyl chloride to (S)-pyrrolidine-2-carbonitrile p-toluenesulfonate is 1.0-1.2:1.
[0048] Preferably, the molar ratio of 3-amino-1-adamantanol to (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile is 1.0-2.0:0.5-1.2.
[0049] Preferably, the adsorbent is one or a combination of more than one of basic alumina and silica gel.
[0050] Preferably, the desiccant is one or a combination of more than one of anhydrous magnesium sulfate, anhydrous sodium sulfate, anhydrous calcium chloride, phosphorus pentoxide, and anhydrous potassium carbonate.
[0051] Preferably, the vacuum drying condition is: vacuum drying at 40-50° C. for 5-8 h.
[0052] Example 1 of the preparation of (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile in step 1:
[0053] Step 11, 20 g of L-prolineamide, 60 mL of dichloromethane and 40 g of di-tert-butyl dicarbonate were mixed for reaction, and the mixture was washed with water and then distilled at a temperature of 10° C. to obtain N-Boc-L-prolineamide;
[0054] Step 12, add N, N-dimethylformamide to the N-Boc-L-proline amide obtained above until it becomes clear, filter the solid, evaporate the solvent, add dichloromethane until it dissolves, wash the organic phase with water, wash and dry, add p-toluenesulfonic acid, reflux for 2h, distill to remove the solvent, add acetonitrile, cool by 0-3°C, filter to obtain (S)-pyrrolidine-2-carbonitrile p-toluenesulfonate;
[0055] Step 13, dissolving the (S)-pyrrolidine-2-carbonitrile p-toluenesulfonate obtained above in 150 mL of dichloromethane and 15 g of triethylamine, adding 16 g of chloroacetyl chloride to react, washing with 150 mL of 10% sodium bicarbonate aqueous solution and purified water, removing the solvent, and crystallizing with 150 mL of n-hexane to obtain (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile.
[0056] Example 2 of the preparation of (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile in step 1:
[0057] Step 11, 40 g of L-prolineamide, 80 mL of dichloromethane and 60 g of di-tert-butyl dicarbonate were mixed for reaction, washed with water and then distilled at a temperature of 12° C. to obtain N-Boc-L-prolineamide;
[0058] Step 12, add N, N-dimethylformamide to the N-Boc-L-proline amide obtained above until it becomes clear, filter the solid, evaporate the solvent, add dichloromethane until it dissolves, wash the organic phase with water, wash and dry, add p-toluenesulfonic acid, reflux for 2h, distill to remove the solvent, add acetonitrile, cool by 0-3°C, filter to obtain (S)-pyrrolidine-2-carbonitrile p-toluenesulfonate;
[0059] Step 13, dissolving the (S)-pyrrolidine-2-carbonitrile p-toluenesulfonate obtained above in 300 mL of dichloromethane and 15 g of triethylamine, adding 30 g of chloroacetyl chloride to react, washing with 300 mL of 10% sodium bicarbonate aqueous solution and purified water, removing the solvent, and crystallizing with 300 mL of n-hexane to obtain (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile.
[0060] Example 3 of preparing vildagliptin by reacting 3-amino-1-adamantanol with (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile in step 2:
[0061] 1. Add 100 mL of methanol, 2 g of triethylamine, 50 g of potassium iodide, 40 g of 3-amino-1-adamantanol, and slowly drop 30 g of (S)-1-(2-chloroacetyl)pyrrole-2-carbonitrile tetrahydrofuran solution 50 mL into a reaction bottle, heat to 50 ° C, react for 12 hours, and obtain a reaction solution.
[0062] 2. The reaction solution obtained in step 1 was subjected to reduced pressure distillation and cooled to 30°C. 40 mL of acetone and 100 g of silica gel were added and stirred for 2 h.
[0063] 3. After stirring in step 2, the mixture was allowed to stand for stratification, and the filter residue was washed with 10 mL of acetone to obtain an organic phase extract;
[0064] 4. Add 50 g of anhydrous magnesium sulfate to the organic phase extract obtained in step 3 above for drying, filter and concentrate under reduced pressure to obtain a concentrated solution;
[0065] 5. Add 10 mL of acetone to the concentrated solution obtained in step 4 above, heat until completely dissolved, cool to 0-3°C for crystallization, filter, and vacuum dry at 50°C for 6 h to obtain vildagliptin.
[0066] Example 4 of preparing vildagliptin by reacting 3-amino-1-adamantanol with (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile in step 2:
[0067] 1. Add 100 mL of acetone, 2 g of tetramethylguanidine, 50 g of potassium iodide, 50 g of 3-amino-1-adamantanol, and slowly drop 40 g of (S)-1-(2-chloroacetyl)pyrrole-2-carbonitrile tetrahydrofuran solution into a reaction bottle, heat to 50 ° C, react for 12 hours, and obtain a reaction solution.
[0068] 2. The reaction solution obtained in step 1 was subjected to reduced pressure distillation and cooled to 30°C. 40 mL of ethyl acetate and 100 g of silica gel were added and stirred for 2 h.
[0069] 3. After stirring in step 2, the mixture was allowed to stand for stratification, and the filter residue was washed with 10 mL of ethyl acetate to obtain an organic phase extract;
[0070] 4. Add 50 g of anhydrous magnesium sulfate to the organic phase extract obtained in step 3 above for drying, filter and concentrate under reduced pressure to obtain a concentrated solution;
[0071] 5. Add 10 mL of ethyl acetate to the concentrated solution obtained in step 4 above, heat until completely dissolved, cool to 0-3°C for crystallization, filter, and vacuum dry at 50°C for 8 h to obtain vildagliptin.
[0072] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. It should be pointed out that a person skilled in the art can make several improvements and modifications without departing from the technical principles of the present invention, and these improvements and modifications should also be regarded as within the scope of protection of the present invention.
Claims
1. A method for synthesizing vildagliptin, characterized in that: The synthetic preparation method comprises the following steps in sequence: Step 1, preparation of (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile: Step 11, mixing L-prolineamide, an organic solvent 1 and di-tert-butyl dicarbonate for reaction, washing with water and then distilling to obtain N-Boc-L-prolineamide; Step 12, add N, N-dimethylformamide to the N-Boc-L-proline amide obtained above until it becomes clear, filter the solid, evaporate the solvent, add dichloromethane until it dissolves, wash the organic phase with water, wash and dry, add p-toluenesulfonic acid, reflux for 1-2h, distill to remove the solvent, add acetonitrile, cool by 0-3°C, filter to obtain (S)-pyrrolidine-2-carbonitrile p-toluenesulfonate; Step 13, dissolving the (S)-pyrrolidine-2-carbonitrile p-toluenesulfonate obtained above in dichloromethane and triethylamine, adding chloroacetyl chloride to react, washing with 10% sodium bicarbonate aqueous solution and purified water, removing the solvent, and crystallizing with n-hexane to obtain (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile; Step 2, 3-amino-1-adamantanol reacts with (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile to prepare vildagliptin: Step 21, adding an organic solvent 2 and an organic base to a reaction bottle, and then adding 3-amino-1-adamantanol and (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile, heating to 40-55° C., reacting for 10-12 hours, to obtain a reaction solution; Step 22, subjecting the reaction solution obtained in the above step 21 to reduced pressure distillation, cooling it to 30-45° C., adding an organic solvent and an adsorbent, and stirring for 1-2 hours; Step 23, after the stirring in the above step 22, the mixture is allowed to stand for stratification, and the filter residue is washed three times with an organic solvent to obtain an organic phase extract; Step 24, adding a desiccant to the organic phase extract obtained in the above step 23 for drying, filtering and concentrating under reduced pressure to obtain a concentrated solution; Step 23: Add organic solvent 3 to the concentrated solution obtained in the above step 24, heat it until it is completely dissolved, cool it to 0-3°C for crystallization, filter it, and vacuum dry it to obtain vildagliptin.
2. The method for synthesizing vildagliptin according to claim 1, wherein: The first organic solvent is a combination of one or more of dichloromethane, chloroform, ethyl acetate, and toluene; the second organic solvent is a combination of one or more of tetrahydrofuran, dimethylacetamide, dichloromethane, ethyl acetate, methanol, and acetone; the third organic solvent is a combination of one or more of toluene, dichloromethane, chloroform, ethyl acetate, methanol, ethanol, isopropanol, acetone, and butanone.
3. The method for synthesizing vildagliptin according to claim 1, wherein: In the step 11, a catalyst 1 is further added, and the catalyst 1 is one or a combination of more than one of butylammonium bromide, tetrabutylammonium chloride, and benzyltriethylammonium chloride; in the step 21, a catalyst 2 is further added, and the catalyst 2 is potassium iodide.
4. The method for synthesizing vildagliptin according to claim 1, wherein: The molar ratio of p-toluenesulfonic acid to L-prolineamide is 1.0-1.2:
1.
5. The method for synthesizing vildagliptin according to claim 1, wherein: The molar ratio of the chloroacetyl chloride to (S)-pyrrolidine-2-carbonitrile p-toluenesulfonate is 1.0-1.2:
1.
6. The method for synthesizing vildagliptin according to claim 1, wherein: The molar ratio of the 3-amino-1-adamantanol to the (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile is 1.0-2.0:0.5-1.
2.
7. The method for synthesizing vildagliptin according to claim 1, wherein: The adsorbent is one or a combination of more than one of alkaline alumina and silica gel.
8. The method for synthesizing vildagliptin according to claim 1, wherein: The desiccant is one or a combination of more than one of anhydrous magnesium sulfate, anhydrous sodium sulfate, anhydrous calcium chloride, phosphorus pentoxide, and anhydrous potassium carbonate.
9. The method for synthesizing vildagliptin according to claim 1, wherein: The vacuum drying conditions are: vacuum drying at 40-50° C. for 5-8 hours.
Citation Information
Patent Citations
N-substituted 2-cyanopyrrolidines
WO2000034241A1
Cited By
Preparation method of Velciguat and intermediate product of Velciguat
CN121735952A
